268 related articles for article (PubMed ID: 11758238)
1. [Retrospective analysis of 15 patients with fungal septicaemia].
Deng G; Wang A
Zhonghua Nei Ke Za Zhi; 2001 Sep; 40(9):594-6. PubMed ID: 11758238
[TBL] [Abstract][Full Text] [Related]
2. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
3. Five-year evaluation of bloodstream yeast infections in a tertiary hospital: the predominance of non-C. albicans Candida species.
Pereira GH; Müller PR; Szeszs MW; Levin AS; Melhem MS
Med Mycol; 2010 Sep; 48(6):839-42. PubMed ID: 20163281
[TBL] [Abstract][Full Text] [Related]
4. Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Fungal Disease Registry of the Canadian Infectious Disease Society.
Yamamura DL; Rotstein C; Nicolle LE; Ioannou S
CMAJ; 1999 Feb; 160(4):493-9. PubMed ID: 10081465
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and outcome for nosocomial breakthrough candidaemia.
Pasqualotto AC; Nedel WL; Machado TS; Severo LC
J Infect; 2006 Mar; 52(3):216-22. PubMed ID: 15936825
[TBL] [Abstract][Full Text] [Related]
6. [Nosocomial fungal infections, analysis of 149 cases].
Liu ZY; Sheng RY; Li XL; Li TS; Wang AX
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):399-402. PubMed ID: 12820917
[TBL] [Abstract][Full Text] [Related]
7. Fluconazole prophylaxis and Candida fungemia in neutropenic children with malignancies.
Cesaro S; Rossetti F; Perilongo G; Rossi L; Zanesco L
Haematologica; 1993; 78(4):249-51. PubMed ID: 8294059
[TBL] [Abstract][Full Text] [Related]
8. When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia.
Benjamin DK; Ross K; McKinney RE; Benjamin DK; Auten R; Fisher RG
Pediatrics; 2000 Oct; 106(4):712-8. PubMed ID: 11015513
[TBL] [Abstract][Full Text] [Related]
9. The predictors of outcome in immunocompetent patients with hematogenous candidiasis.
Safdar A; Bannister TW; Safdar Z
Int J Infect Dis; 2004 May; 8(3):180-6. PubMed ID: 15109594
[TBL] [Abstract][Full Text] [Related]
10. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality.
Weinberger M; Leibovici L; Perez S; Samra Z; Ostfeld I; Levi I; Bash E; Turner D; Goldschmied-Reouven A; Regev-Yochay G; Pitlik SD; Keller N
J Hosp Infect; 2005 Oct; 61(2):146-54. PubMed ID: 16009456
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
[TBL] [Abstract][Full Text] [Related]
14. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
Klevay MJ; Horn DL; Neofytos D; Pfaller MA; Diekema DJ;
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):152-7. PubMed ID: 19376667
[TBL] [Abstract][Full Text] [Related]
15. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
[TBL] [Abstract][Full Text] [Related]
16. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.
Garey KW; Rege M; Pai MP; Mingo DE; Suda KJ; Turpin RS; Bearden DT
Clin Infect Dis; 2006 Jul; 43(1):25-31. PubMed ID: 16758414
[TBL] [Abstract][Full Text] [Related]
17. Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol.
Krcmery V; Mateicka F; Kunová A; Spánik S; Gyarfás J; Sycová Z; Trupl J
Support Care Cancer; 1999 Jan; 7(1):39-43. PubMed ID: 9926973
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Candida tropicalis fungemia in patients with cancer.
Kontoyiannis DP; Vaziri I; Hanna HA; Boktour M; Thornby J; Hachem R; Bodey GP; Raad II
Clin Infect Dis; 2001 Nov; 33(10):1676-81. PubMed ID: 11568858
[TBL] [Abstract][Full Text] [Related]
19. Candida krusei fungemia. An escalating serious infection in immunocompromised patients.
Abbas J; Bodey GP; Hanna HA; Mardani M; Girgawy E; Abi-Said D; Whimbey E; Hachem R; Raad I
Arch Intern Med; 2000 Sep; 160(17):2659-64. PubMed ID: 10999981
[TBL] [Abstract][Full Text] [Related]
20. Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital, 1996-2004.
Al-Tawfiq JA
Int J Infect Dis; 2007 May; 11(3):239-44. PubMed ID: 16859945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]